Related Experiment Video
Updated: Jun 17, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Mutated ras induced PLD1 gene expression through increased Sp1 transcription factor
Siqiang Gao1, Masashi Murakami, Hiromi Ito
1Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya, Japan.
Abstract:
The underlying mechanisms of oncogene-induced phospholipase D (PLD) activation have not been fully elucidated. The effect of the mutated-ras on PLD mRNA was examined using colon cancer cell lines as well as mock- and mutated ras-transfected NIH3T3 cells. Ras-mutation and activation were correlated, and cells with enhanced ras-activation showed increased PLD1 mRNA and protein. Analysis of the 5' PLD1 promoter using a representative cell line, DLD-1 and also mutated ras-NIH3T3, showed one Sp1-site as the important ras-responsible motif. Spl inhibition with mithramycin A and Spl siRNA inhibited PLD1 protein expression and its promoter activity. Sp1 but not Sp3 protein level and increased Sp1-motif binding activity were correlated with ras activation. Furthermore, overexpression of Sp1 in drosophila SL2 cells lacking Sp family proteins increased PLD1 promoter activity. EMSA and chromatin immunoprecipitation assay confirmed the importance of Sp1 protein binding to the Sp1-motif in ras-induced PLD1 mRNA expression.
Insights
Mutated Ras oncogenes increase phospholipase D1 (PLD1) expression by activating the Sp1 transcription factor. This study identifies Sp1 as a key mediator in Ras-driven oncogenesis, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- The mechanisms linking oncogene activation to phospholipase D (PLD) activity remain unclear.
- Oncogenic mutations, particularly in Ras, are implicated in various cancers, but their direct effects on PLD regulation need further investigation.
Purpose of the Study:
- To elucidate the role of mutated Ras in regulating phospholipase D1 (PLD1) gene expression.
- To identify the specific transcription factors and regulatory elements involved in Ras-mediated PLD1 activation.
Main Methods:
- Utilized colon cancer cell lines and NIH3T3 cells with mock or mutated Ras transfection.
- Performed 5' promoter analysis, Sp1 inhibition studies (mithramycin A, siRNA), and Sp1 overexpression experiments in Drosophila SL2 cells.
- Employed Electrophoretic Mobility Shift Assay (EMSA) and Chromatin Immunoprecipitation (ChIP) assays.
Main Results:
- Mutated Ras activation correlated with increased PLD1 mRNA and protein levels.
- A specific Sp1-binding site within the PLD1 promoter was identified as crucial for Ras-induced expression.
- Inhibition of Sp1 activity or protein levels reduced PLD1 expression and promoter activity.
- Sp1 protein levels and its binding to the PLD1 promoter motif increased with Ras activation.
Conclusions:
- Sp1 is a critical mediator of Ras-induced PLD1 expression.
- Ras activation enhances PLD1 transcription through increased Sp1 binding to its promoter motif.
- Targeting the Sp1-PLD1 interaction may offer a strategy for inhibiting oncogene-driven cancer progression.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Induced Pluripotent Stem Cells
Somatic cells are...